吴晶 - 天津大学 - 药物科学与技术学院

个人简介

Education Experience： 2007 Ph. D. Shenyang Pharmaceutical & Peking University Professional Experience： 2011-2015 Associated Professor Tianjin University 2013-2014 Visiting Scholar USC 2007-2011 Assistant Professor Tianjin University

研究领域

The research in the group of Wu is encompassed in the areas of a) Pharmacoeconomics, b) Pharmaceutical Policy Evaluation, c) Health care costs, Health insurance Markets and Benefits Design, d) Comparative Effectiveness & Outcomes Research, and e) Health related Quality of Life and Health utility Research.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema Jing Wu, Clive Adams, Xiaoning He, Fang Qi & Jun Xia Systematic Reviews volume 12, Article number: 189 (2023) Incorporating absolute effects to enrich interpretation of findings from meta-analyses Jing Wu，Shitong Xie，Xiaoning He，Tianqi Hong，Liang Yao Published:September, 2023 DOI:https://doi.org/10.1016/S1470-2045(23)00384-4 Xie, S., Wu, J. & Chen, G. Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population. Eur J Health Econ (2023). https://doi.org/10.1007/s10198-023-01566-x The trend in quality of life of Chinese population: analysis based on population health surveys from 2008 to 2020 Dingyao Wang, Shitong Xie, Jing Wu & Bei Sun BMC Public Health volume 23, Article number: 167 (2023) Xu, T., Yang, X., He, X. et al. Correction: The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors. J Epidemiol Glob Health 13, 162 (2023). https://doi.org/10.1007/s44197-023-00087-3 Xu, T., Yang, X., He, X. et al. The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors. J Epidemiol Glob Health 13, 154–161 (2023). https://doi.org/10.1007/s44197-022-00081-1 Dong, X., He, X. & Wu, J. Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting. PharmacoEconomics 40, 1187–1205 (2022). https://doi.org/10.1007/s40273-022-01182-2 Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China Liu Jia,Cao Lidan,Wu Jing ISSN:2296-2565 2022 Container-title:Frontiers in Public Health Confidence of evidence should be considered in ranking of treatments in the network meta-analysis The Lancet Psychiatry 2022 | Journal article DOI: 10.1016/S2215-0366(22)00063-3 EID: 2-s2.0-85126536888 Part of ISSN: 22150374 22150366 CONTRIBUTORS: Xie, S.; Zhu, Y.; Wang, X.; Wu, J.; Wang, Q. Discrete choice experiment with duration versus time trade-off: a comparison of test–retest reliability of health utility elicitation approaches in SF-6Dv2 valuation Quality of Life Research 2022 | Journal article DOI: 10.1007/s11136-022-03159-2 EID: 2-s2.0-85130687015 Part of ISSN: 15732649 09629343 CONTRIBUTORS: Xie, S.; Wu, J.; Chen, G. Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model Applied Health Economics and Health Policy 2022 | Journal article DOI: 10.1007/s40258-022-00732-1 EID: 2-s2.0-85128941846 Part of ISSN: 11791896 11755652 CONTRIBUTORS: Liu, J.; He, X.; Wu, J. Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life European Journal of Health Economics 2022 | Journal article DOI: 10.1007/s10198-021-01384-z EID: 2-s2.0-85117130812 Part of ISSN: 16187601 16187598 CONTRIBUTORS: Cai, D.; Shi, S.; Jiang, S.; Si, L.; Wu, J.; Jiang, Y. Policy Updates on Access to and Affordability of Innovative Medicines in China Value in Health Regional Issues 2022 | Journal article DOI: 10.1016/j.vhri.2021.12.003 EID: 2-s2.0-85125259007 Part of ISSN: 22121102 22121099 CONTRIBUTORS: Liu, G.G.; Wu, J.; He, X.; Jiang, Y. Population Norms for SF-6Dv2 and EQ-5D-5L in China Applied Health Economics and Health Policy 2022 | Journal article DOI: 10.1007/s40258-022-00715-2 EID: 2-s2.0-85124355062 Part of ISSN: 11791896 11755652 CONTRIBUTORS: Xie, S.; Wu, J.; Xie, F. The Impact of Hyperkalemia on Mortality and Healthcare Resource Utilization Among Patients With Chronic Kidney Disease: A Matched Cohort Study in China Frontiers in Public Health 2022 | Journal article DOI: 10.3389/fpubh.2022.855395 EID: 2-s2.0-85127937953 Part of ISSN: 22962565 CONTRIBUTORS: Zhang, J.; He, X.; Wu, J. Comparative efficacy of dabrafenib + trametinib versus treatment options for metastatic melanoma in first-line settings Journal of Comparative Effectiveness Research 2021 | Journal article DOI: 10.2217/cer-2020-0249 EID: 2-s2.0-85102206372 Part of ISSN: 20426313 20426305 CONTRIBUTORS: Wu, J.; Das, J.; Kalra, M.; Ratto, B. Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective BMC Ophthalmology 2021 | Journal article DOI: 10.1186/s12886-021-01997-1 EID: 2-s2.0-85106743069 Part of ISSN: 14712415 CONTRIBUTORS: Ni, W.; Liu, J.; Jiang, Y.; Wu, J. Differences in lung cancer treatment preferences among oncologists, patients and family members: A semi-structured qualitative study in China Patient Preference and Adherence 2021 | Journal article DOI: 10.2147/PPA.S299399 EID: 2-s2.0-85104940203 Part of ISSN: 1177889X CONTRIBUTORS: He, X.; Zhang, M.; Wu, J.; Xu, S.; Jiang, X.; Wang, Z.; Zhang, S.; Xie, F. Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China Diabetes Therapy 2021 | Journal article DOI: 10.1007/s13300-020-00967-y EID: 2-s2.0-85096239385 Part of ISSN: 18696961 18696953 CONTRIBUTORS: He, X.; Zhang, Y.; Zhou, Y.; Dong, C.; Wu, J. Disparities in Hepatocellular Carcinoma Survival by Insurance Status: A Population-Based Study in China Frontiers in Public Health 2021 | Journal article DOI: 10.3389/fpubh.2021.742355 EID: 2-s2.0-85119480453 Part of ISSN: 22962565 CONTRIBUTORS: Wu, J.; Liu, C.; Wang, F. Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study PharmacoEconomics - Open 2021 | Journal article DOI: 10.1007/s41669-020-00212-z EID: 2-s2.0-85098779579 Part of ISSN: 25094254 25094262 CONTRIBUTORS: Yang, F.; Jiang, S.; He, X.-N.; Li, H.-C.; Wu, H.-Y.; Zhang, T.-T.; Wu, J. Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios British Journal of Clinical Pharmacology 2021 | Journal article DOI: 10.1111/bcp.14860 EID: 2-s2.0-85105067101 Part of ISSN: 13652125 03065251 CONTRIBUTORS: Jiang, Y.; Cai, D.; Chen, D.; Jiang, S.; Si, L.; Wu, J. Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis Advances in Therapy 2021 | Journal article DOI: 10.1007/s12325-021-01637-6 EID: 2-s2.0-85101019191 Part of ISSN: 18658652 0741238X CONTRIBUTORS: Jiang, Y.; Liu, J.; Chen, X.; Yang, W.; Jia, W.; Wu, J. Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique Social Science and Medicine 2021 | Journal article DOI: 10.1016/j.socscimed.2021.114018 EID: 2-s2.0-85105747525 Part of ISSN: 18735347 02779536 CONTRIBUTORS: Osman, A.M.Y.; Wu, J.; He, X.; Chen, G. Heterogeneity in Price Elasticity of Medicine Demand in China: Moderate Effect From Economic Incentive and Quality Difference Frontiers in Pharmacology 2021 | Journal article DOI: 10.3389/fphar.2021.688069 EID: 2-s2.0-85112695792 Part of ISSN: 16639812 CONTRIBUTORS: Zhao, M.; Nie, P.; Wu, J. Incorporating future unrelated medical costs in cost-effectiveness analysis in China BMJ Global Health 2021 | Journal article DOI: 10.1136/bmjgh-2021-006655 EID: 2-s2.0-85118846122 Part of ISSN: 20597908 CONTRIBUTORS: Jiang, S.; Wang, Y.; Zhou, J.; Jiang, Y.; Liu, G.G.-E.; Wu, J. Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension PharmacoEconomics 2021 | Journal article DOI: 10.1007/s40273-020-00997-1 EID: 2-s2.0-85101071092 Part of ISSN: 11792027 11707690 CONTRIBUTORS: Wu, J.; Xie, S.; He, X.; Chen, G.; Bai, G.; Feng, D.; Hu, M.; Jiang, J.; Wang, X.; Wu, H. et al. Cost-Effectiveness Analysis of Dabrafenib Plus Trametinib and Vemurafenib as First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in China International Journal of Environmental Research and Public Health 2021-06 | Journal article | Author DOI: 10.3390/ijerph18126194 CONTRIBUTORS: Tianfu Gao; Jia Liu; Jing Wu Trends and Age-Period-Cohort Effects on the Prevalence, Incidence and Mortality of Hepatocellular Carcinoma from 2008 to 2017 in Tianjin, China International Journal of Environmental Research and Public Health 2021-06 | Journal article | Author DOI: 10.3390/ijerph18116034 CONTRIBUTORS: Chengyu Liu; Jing Wu; Zheng Chang Addressing methodological and ethical issues in practicing health economic evaluation in China Journal of Global Health 2020 | Journal article DOI: 10.7189/jogh.10.020322 EID: 2-s2.0-85094855776 Part of ISSN: 20472986 20472978 CONTRIBUTORS: Jiang, S.; Chen, Z.; Wu, J.; Zang, X.; Jiang, Y. Adherence to statins and its impact on clinical outcomes: A retrospective population-based study in China BMC Cardiovascular Disorders 2020 | Journal article DOI: 10.1186/s12872-020-01566-2 EID: 2-s2.0-85086356364 Part of ISSN: 14712261 CONTRIBUTORS: Zhao, B.; He, X.; Wu, J.; Yan, S. An Empirical Study on the Change of Medicine Price Level in China,中国药品价格水平变化实证研究 Chinese Pharmaceutical Journal 2020 | Journal article DOI: 10.11669/cpj.2020.17.013 EID: 2-s2.0-85096584374 Part of ISSN: 10012494 CONTRIBUTORS: Cao, L.-D.; Zhou, Y.-Y.; Wu, J. Association of severe hypoglycemia with all-cause mortality and complication risks among patients with type 2 diabetes mellitus in China Diabetes Research and Clinical Practice 2020 | Journal article DOI: 10.1016/j.diabres.2020.108493 EID: 2-s2.0-85094894146 Part of ISSN: 18728227 01688227 CONTRIBUTORS: Zhang, J.; He, X.; Zhang, L.; Wang, K.; Chen, H.; Wu, J. COVID-19 pandemic in China: Context, experience and lessons Health Policy and Technology 2020 | Journal article DOI: 10.1016/j.hlpt.2020.08.006 EID: 2-s2.0-85090303550 Part of ISSN: 22118845 22118837 CONTRIBUTORS: Xu, W.; Wu, J.; Cao, L. Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China Value in Health 2020 | Journal article DOI: 10.1016/j.jval.2020.06.010 EID: 2-s2.0-85090300355 Part of ISSN: 15244733 10983015 CONTRIBUTORS: Xie, S.; Wu, J.; He, X.; Chen, G.; Brazier, J.E. EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China Diabetes Therapy 2020 | Journal article DOI: 10.1007/s13300-020-00788-z EID: 2-s2.0-85081664139 Part of ISSN: 18696961 18696953 CONTRIBUTORS: Zhang, Y.; Wu, J.; Chen, Y.; Shi, L. Evidence-based traditional Chinese medicine research: Beijing Declaration Journal of Evidence-Based Medicine 2020 | Journal article DOI: 10.1111/jebm.12389 EID: 2-s2.0-85085495571 Part of ISSN: 17565391 17565383 CONTRIBUTORS: Zhang, J.; Li, Y.; Zhang, B.; Chen, K.; Wang, Q.; Li, Z.; Sun, S.; Tian, J.; Sun, X.; Yao, C. et al. Formulate technical guidance for real-world studies of traditional Chinese medicine in China to promote the transformation of clinical research of Chinese patent medicine into decision evidence,制定中国中成药真实世界研究技术指导原则，促进中成药临床研究向决策证据转化 Chinese Journal of Evidence-Based Medicine 2020 | Journal article DOI: 10.7507/1672-2531.202006027 EID: 2-s2.0-85092037446 Part of ISSN: 16722531 CONTRIBUTORS: Sun, X.; Zhang, J.; Wang, W.; Tan, J.; Peng, X.; Gao, P.; Wu, J.; Wen, Z.; Luo, J.; Li, L. et al. International experience with performance-based risk-sharing arrangements: Implications for the Chinese innovative pharmaceutical market International Journal of Technology Assessment in Health Care 2020 | Journal article DOI: 10.1017/S0266462320000653 EID: 2-s2.0-85091759565 Part of ISSN: 14716348 02664623 CONTRIBUTORS: Xu, W.; Wu, J. Perioperative inhaled corticosteroids treatment is associated with decreased length-of-stay and direct medical costs in high-respiratory-risk surgeries Journal of Medical Economics 2020 | Journal article DOI: 10.1080/13696998.2019.1699798 EID: 2-s2.0-85076885340 Part of ISSN: 1941837X 13696998 CONTRIBUTORS: Zhu, X.; Zhang, P.; Lou, C.; Wu, J. The Simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing Quality of Life Research 2020 | Journal article DOI: 10.1007/s11136-020-02419-3 EID: 2-s2.0-85078602438 Part of ISSN: 15732649 09629343 CONTRIBUTORS: Wu, J.; Xie, S.; He, X.; Chen, G.; Brazier, J.E. Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration Medical Care 2020 | Journal article DOI: 10.1097/MLR.0000000000001324 EID: 2-s2.0-85084942834 Part of ISSN: 15371948 00257079 CONTRIBUTORS: Mulhern, B.J.; Bansback, N.; Norman, R.; Brazier, J.; Alonso, J.; Bestmann, B.; Bjorner, J.; Cruz, L.; Daroudi, R.; Ferreira, L. et al. Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: An economic modelling analysis BMJ Open 2019 | Journal article DOI: 10.1136/bmjopen-2019-031186 EID: 2-s2.0-85075564334 Part of ISSN: 20446055 CONTRIBUTORS: Jiang, Y.; Ni, W.; Wu, J. Developing technical guidance for real-world data and studies to achieve better production and use of real-world evidence in China,建立真实世界数据与研究技术规范，促进中国真实世界证据的生产与使用 Chinese Journal of Evidence-Based Medicine 2019 | Journal article DOI: 10.7507/1672-2531.201905082 EID: 2-s2.0-85079622471 Part of ISSN: 16722531 CONTRIBUTORS: Sun, X.; Tan, J.; Wang, W.; Gao, P.; Peng, X.; Wen, Z.; Wang, L.; Wu, J.; Shu, X.; Wang, Y. et al.